Financials

  • Market Capitalization 80.29 M
  • Employee 13
  • Founded 2018
  • CEO N/A
  • Website www.maiabiotech.com
  • Headquarter Delaware, United States
  • FIGI BBG0113Q7J88
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4017
ACET
Adicet Bio, Inc. - Common Stock
9.06 USD+0.55%-1.63%+7.86%+1141.10%84.82 M USD
4023
GOSS
Gossamer Bio, Inc. - Common Stock
0.17 USD0.00%+13.33%-19.05%-92.98%83.10 M USD
4056
TENX
Tenax Therapeutics, Inc. - Common Stock
2.13 USD-2.74%+25.29%-85.70%-71.79%79.71 M USD
4064
TELO
Telomir Pharmaceuticals, Inc. - Common Stock
1.14 USD-4.20%+0.88%-6.56%-12.31%78.40 M USD

Frequently asked questions about MAIA Biotechnology, Inc.

What is the MAIA Biotechnology, Inc. stock price today?

The current price of MAIA Biotechnology, Inc. (MAIA) is 1.32. Over the past 24 hours, the stock has changed by -5.04%. Follow the MAIA chart for real-time price dynamics.

What is the stock ticker of MAIA Biotechnology, Inc.?

MAIA Biotechnology, Inc. trades under the ticker MAIA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is MAIA Biotechnology, Inc. stock going up?

MAIA has changed by -2.94% over the last week, +10.92% over the last month, and -36.54% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of MAIA Biotechnology, Inc.?

MAIA Biotechnology, Inc. currently has a market capitalization of 80.29 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were MAIA Biotechnology, Inc. earnings last quarter?

Last quarter, MAIA Biotechnology, Inc. reported earnings of -0.13 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was MAIA Biotechnology, Inc. net income for the last quarter?

MAIA Biotechnology, Inc. reported net income of -7.94 M for the last quarter. The previous quarter showed -6.37 M, which means net income changed by -24.71%.

How many employees does MAIA Biotechnology, Inc. have?

As of the latest available data, MAIA Biotechnology, Inc. has 13 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy MAIA Biotechnology, Inc. stock?

You can buy MAIA Biotechnology, Inc. (MAIA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in MAIA Biotechnology, Inc. stock?

Investing in MAIA Biotechnology, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MAIA chart and related analysis on metatrader.com as part of your research.

MAIA Biotechnology, Inc. Common Stock

MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells.

News